iCo Therapeutics (iCo Therapeutics) Scaled Net Operating Assets : -3.43 (As of Mar. 2021)

View and export this data going back to 2009. Start your Free Trial

What is iCo Therapeutics Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

iCo Therapeutics's operating assets for the quarter that ended in Mar. 2021 was $0.07 Mil. iCo Therapeutics's operating liabilities for the quarter that ended in Mar. 2021 was $1.53 Mil. iCo Therapeutics's Total Assets for the quarter that ended in Dec. 2020 was $0.43 Mil. Therefore, iCo Therapeutics's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2021 was -3.43.

iCo Therapeutics Scaled Net Operating Assets Historical Data

The historical data trend for iCo Therapeutics's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iCo Therapeutics Scaled Net Operating Assets Chart

iCo Therapeutics Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Scaled Net Operating Assets

Get a 7-Day Free Trial

-0.01

-0.02

-0.44

-1.90

-0.57

iCo Therapeutics Quarterly Data
	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21
Scaled Net Operating Assets	Get a 7-Day Free Trial															-0.28	-0.55	-0.76	-1.33	-3.43

Competitive Comparison of iCo Therapeutics's Scaled Net Operating Assets

For the Biotechnology subindustry, iCo Therapeutics's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

iCo Therapeutics's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, iCo Therapeutics's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where iCo Therapeutics's Scaled Net Operating Assets falls into.

iCo Therapeutics Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

iCo Therapeutics's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2020 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2020 )
=	(Operating Assets (A: Dec. 2020 )	-	Operating Liabilities (A: Dec. 2020 ))	/	Total Assets (A: Dec. 2019 )
=	(0.375	-	1.013)	/	1.115
=	-0.57

where

	Operating Assets		(A: Dec. 2020 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	0.426	-	0.051
=	0.375

	Operating Liabilities		(A: Dec. 2020 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	1.013	-	0	-	0
=	1.013

iCo Therapeutics's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2021 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Mar. 2021 )
=	(Operating Assets (Q: Mar. 2021 )	-	Operating Liabilities (Q: Mar. 2021 ))	/	Total Assets (Q: Dec. 2020 )
=	(0.065	-	1.528)	/	0.426
=	-3.43

where

	Operating Assets		(Q: Mar. 2021 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	1.738	-	1.673
=	0.065

	Operating Liabilities		(Q: Mar. 2021 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	1.528	-	0	-	0
=	1.528

iCo Therapeutics Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of iCo Therapeutics's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

iCo Therapeutics (iCo Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » iCo Therapeutics Inc (GREY:ICOTF) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

777 Hornby Street, 6th Floor, Vancouver, BC, CAN, V6Z 1S4

Website

http://www.icotherapeutics.com

iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between the cells of the immune system. Geographically, it operates in Canada and Australia.

iCo Therapeutics (iCo Therapeutics) Headlines

No Headlines